Search research articles
Contact Us
Filters
Showing results (51-60 of 121) with videos related to
Page
of 13
Sort By:
The Oncologist
|
October 5, 2014
A phase I/II study of XELIRI plus bevacizumab as second-line chemotherapy for Japanese patients with metastatic colorectal cancer (BIX study)
Yasuo Hamamoto, Tatsuro Yamaguchi, Tomohiro Nishina, et al.
Digestion
|
December 6, 2025
Diagnostic Performance of Fecal Biomarkers and Their Correlation with Endoscopic Severity in Immune Checkpoint Inhibitor- Related Colitis
Ryo Morikawa, Toshimitsu Fujii, Akiko Tamura, et al.
Anticancer Research
|
September 21, 2012
Chemoresistance is associated with cancer stem cell-like properties and epithelial-to-mesenchymal transition in pancreatic cancer cells
Motoko Izumiya, Ayano Kabashima, Hajime Higuchi, et al.
Japanese Journal of Clinical Oncology
|
September 10, 2013
Randomized Phase III study of 5-fluorouracil continuous infusion vs. sequential methotrexate and 5-fluorouracil therapy in far advanced gastric cancer with peritoneal metastasis (JCOG0106)
Kuniaki Shirao, Narikazu Boku, Yasuhide Yamada, et al.
Japanese Journal of Clinical Oncology
|
February 3, 2016
Inter-institutional survival heterogeneity in chemoradiation therapy for esophageal cancer: exploratory analysis of the JCOG0303 study
Yasuo Hamamoto, Junki Mizusawa, Hiroshi Katayama, et al.
Japanese Journal of Clinical Oncology
|
December 20, 2015
Multicenter questionnaire survey on patterns of care for elderly patients with esophageal squamous cell carcinoma by the Japan Esophageal Oncology Group
Yasuo Hamamoto, Yasunori Akutsu, Fumio Nagashima, et al.
Investigational New Drugs
|
March 25, 2018
Post-progression survival following second-line chemotherapy in patients with advanced pancreatic cancer previously treated with gemcitabine: a meta-analysis
Akiyoshi Kasuga, Yasuo Hamamoto, Ayano Takeuchi, et al.
Future Oncology (London, England)
|
April 21, 2021
Analysis of risk factors for immune-related adverse events in various solid tumors using real-world data
Keitaro Shimozaki, Yasutaka Sukawa, Yasunori Sato, et al.
Journal of Gastroenterology
|
May 31, 2012
Anti-high mobility group box 1 and box 2 non-histone chromosomal proteins (HMGB1/HMGB2) antibodies and anti-Saccharomyces cerevisiae antibodies (ASCA): accuracy in differentially diagnosing UC and CD and correlation with inflammatory bowel disease phenotype
Hiromasa Takaishi, Takanori Kanai, Atsushi Nakazawa, et al.
Gastrointestinal Endoscopy
|
May 12, 2018
Technical feasibility and oncologic safety of diagnostic endoscopic resection for superficial esophageal cancer
Masashi Takeuchi, Koichi Suda, Yasuo Hamamoto, et al.
Page
of 13
Search research articles
Search
Showing results (51-60 of 121) with videos related to
Sort By:
Page
of 13
The Oncologist
|
October 5, 2014
A phase I/II study of XELIRI plus bevacizumab as second-line chemotherapy for Japanese patients with metastatic colorectal cancer (BIX study)
Yasuo Hamamoto, Tatsuro Yamaguchi, Tomohiro Nishina, et al.
Digestion
|
December 6, 2025
Diagnostic Performance of Fecal Biomarkers and Their Correlation with Endoscopic Severity in Immune Checkpoint Inhibitor- Related Colitis
Ryo Morikawa, Toshimitsu Fujii, Akiko Tamura, et al.
Anticancer Research
|
September 21, 2012
Chemoresistance is associated with cancer stem cell-like properties and epithelial-to-mesenchymal transition in pancreatic cancer cells
Motoko Izumiya, Ayano Kabashima, Hajime Higuchi, et al.
Japanese Journal of Clinical Oncology
|
September 10, 2013
Randomized Phase III study of 5-fluorouracil continuous infusion vs. sequential methotrexate and 5-fluorouracil therapy in far advanced gastric cancer with peritoneal metastasis (JCOG0106)
Kuniaki Shirao, Narikazu Boku, Yasuhide Yamada, et al.
Japanese Journal of Clinical Oncology
|
February 3, 2016
Inter-institutional survival heterogeneity in chemoradiation therapy for esophageal cancer: exploratory analysis of the JCOG0303 study
Yasuo Hamamoto, Junki Mizusawa, Hiroshi Katayama, et al.
Japanese Journal of Clinical Oncology
|
December 20, 2015
Multicenter questionnaire survey on patterns of care for elderly patients with esophageal squamous cell carcinoma by the Japan Esophageal Oncology Group
Yasuo Hamamoto, Yasunori Akutsu, Fumio Nagashima, et al.
Investigational New Drugs
|
March 25, 2018
Post-progression survival following second-line chemotherapy in patients with advanced pancreatic cancer previously treated with gemcitabine: a meta-analysis
Akiyoshi Kasuga, Yasuo Hamamoto, Ayano Takeuchi, et al.
Future Oncology (London, England)
|
April 21, 2021
Analysis of risk factors for immune-related adverse events in various solid tumors using real-world data
Keitaro Shimozaki, Yasutaka Sukawa, Yasunori Sato, et al.
Journal of Gastroenterology
|
May 31, 2012
Anti-high mobility group box 1 and box 2 non-histone chromosomal proteins (HMGB1/HMGB2) antibodies and anti-Saccharomyces cerevisiae antibodies (ASCA): accuracy in differentially diagnosing UC and CD and correlation with inflammatory bowel disease phenotype
Hiromasa Takaishi, Takanori Kanai, Atsushi Nakazawa, et al.
Gastrointestinal Endoscopy
|
May 12, 2018
Technical feasibility and oncologic safety of diagnostic endoscopic resection for superficial esophageal cancer
Masashi Takeuchi, Koichi Suda, Yasuo Hamamoto, et al.
Page
of 13